Importantly and to the best of our knowledge, this is the first study to investigate the chronic effect of WT on the muscular expression of miRNA-126, VEGF, SPRED-1 and PI3KR2 in patients with PAD. This evidence concerns the gene VEGFA and peripheral arterial disease.